Literature DB >> 16187744

Expression of the proto-oncogene Fos after exposure to radiofrequency radiation relevant to wireless communications.

Timothy D Whitehead1, Bernard H Brownstein, Jesse J Parry, Dominic Thompson, Bibianna A Cha, Eduardo G Moros, Buck E Rogers, Joseph L Roti Roti.   

Abstract

In this study the expression levels of the proto-oncogene Fos were measured after exposure to radiofrequency (RF) radiation at two relatively high specific absorption rates (SARs) of 5 and 10 W/kg for three types of modulated signals: 847.74 MHz code division multiple access (CDMA), 835.62 MHz frequency division multiple access (FDMA), and 836.55 MHz time division multiple access (TDMA). This work was undertaken to confirm a previous report by Goswami et al. (Radiat. Res. 151, 300-309, 1999) that CDMA and FDMA radiation caused small but statistically significant increases in Fos levels as cells entered plateau phase during exposure. No effects on Myc or Jun levels were observed in that study. Therefore, in the present study, analyses were restricted to Fos expression during the transition from exponential growth to plateau phase. Fos expression was measured using the real-time polymerase chain reaction (RT-PCR) technique. Serum-stimulated C3H 10T(1/2) cells were used as a positive control for Fos expression. Possible influences of final cell number or pH variability on Fos expression were evaluated. Expression of Fos mRNA in C3H 10T(1/2) cells was not significantly different from that found after sham exposure at either SAR level for any signal modulation. Therefore, the results of Goswami et al. could not be confirmed.

Entities:  

Mesh:

Year:  2005        PMID: 16187744     DOI: 10.1667/rr3446.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  3 in total

1.  The effects of single and repeated exposure to 2.45 GHz radiofrequency fields on c-Fos protein expression in the paraventricular nucleus of rat hypothalamus.

Authors:  T Jorge-Mora; M J Misa-Agustiño; J A Rodríguez-González; F J Jorge-Barreiro; F J Ares-Pena; E López-Martín
Journal:  Neurochem Res       Date:  2011-08-05       Impact factor: 3.996

2.  Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers.

Authors:  Summer B Dewdney; B J Rimel; Premal H Thaker; Dominic M Thompson; Amy Schmidt; Phyllis Huettner; David G Mutch; Feng Gao; Paul J Goodfellow
Journal:  Clin Cancer Res       Date:  2011-03-03       Impact factor: 12.531

3.  Infrequent methylation of the DUSP6 phosphatase in endometrial cancer.

Authors:  Katherine B Chiappinelli; B J Rimel; L Stewart Massad; Paul J Goodfellow
Journal:  Gynecol Oncol       Date:  2010-07-16       Impact factor: 5.482

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.